Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Herlev Hospital
Thomas Jefferson University
GeoVax, Inc.
Herlev Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Washington University School of Medicine
Arog Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Herlev Hospital
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Herlev Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Columbia University
Columbia University
Gruppo Italiano Malattie EMatologiche dell'Adulto
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
SCRI Development Innovations, LLC
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center